Elizabeth Weatherman Net Worth

The estimated Net Worth of Elizabeth H Weatherman is at least $103 Million dollars as of 17 April 2023. Ms. Weatherman owns over 5,000 units of Nevro Corp stock worth over $680,378 and over the last 9 years she sold NVRO stock worth over $101,957,288. In addition, she makes $445,187 as Independent Director at Nevro Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Weatherman NVRO stock SEC Form 4 insiders trading

Elizabeth has made over 24 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 5,000 units of NVRO stock worth $209,550 on 17 April 2023.

The largest trade she's ever made was selling 4,500,000 units of Nevro Corp stock on 23 November 2015 worth over $93,690,000. On average, Elizabeth trades about 51,017 units every 25 days since 2015. As of 17 April 2023 she still owns at least 144,454 units of Nevro Corp stock.

You can see the complete history of Ms. Weatherman stock trades at the bottom of the page.

Elizabeth Weatherman biography

Elizabeth H. (Bess) Weatherman is Independent Director of the company. Ms. Weatherman has served as special limited partner of Warburg Pincus LLC, a leading global private equity firm, since 2016. Ms. Weatherman joined Warburg Pincus in 1988, became a partner in 1996 and served as a member of the Executive Management Group from 2001 to January 2016. She led the firm’s Healthcare Group from 2008 to January 2015. Ms. Weatherman currently serves as a director of each of Wright Medical Group N.V., Vapotherm, Inc. and Silk Road Medical, Inc. She received a B.A. in English from Mount Holyoke College and an M.B.A. from Stanford Graduate School of Business.

What is the salary of Elizabeth Weatherman?

As the Independent Director of Nevro Corp, the total compensation of Elizabeth Weatherman at Nevro Corp is $445,187. There are 10 executives at Nevro Corp getting paid more, with D.Keith Grossman having the highest compensation of $13,877,700.

How old is Elizabeth Weatherman?

Elizabeth Weatherman is 60, she's been the Independent Director of Nevro Corp since 2019. There are 10 older and 11 younger executives at Nevro Corp. The oldest executive at Nevro Corp is Frank Fischer, 78, who is the Independent Director.

What's Elizabeth Weatherman's mailing address?

Elizabeth's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.

Insiders trading at Nevro Corp

Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo und & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.

What does Nevro Corp do?

headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.

Complete history of Ms. Weatherman stock trades at Insulet, Wright Medical NV, Nevro Corp, Vapotherm Inc und Silk Road Medical Inc

Nevro Corp executives and stock owners

Nevro Corp executives and other stock owners filed with the SEC include:

• D.Keith Grossman,
  Chairman of the Board, President, Chief Executive Officer
• Niamh Pellegrini,
  Chief Commercial Officer
• Michael Carter,
  Vice President - Global Sales
• Christopher Christoforou,
  Vice President - Research and Development
• D. Keith Grossman,
  Chairman, CEO & Pres
• Patrick Schmitz,
  Vice President - Operations
• Kashif Rashid,
  Chief Compliance Officer, General Counsel, Corporate Secretary
• Andrew H. Galligan,
  Exec. Officer
• Kashif Rashid,
  Gen. Counsel, Corp. Sec. & Chief Compliance Officer
• Roderick H. MacLeod,
  Chief Financial Officer
• Elizabeth Weatherman,
  Independent Director
• Kevin O'Boyle,
  Independent Director
• Karen Prange,
  Independent Director
• Michael DeMane,
  Lead Independent Director
• Wilfred Jaeger,
  Independent Director
• Shawn McCormick,
  Independent Director
• Frank Fischer,
  Independent Director
• Brad Vale,
  Independent Director
• David Caraway,
  Chief Medical Officer
• Donald Middlebrook,
  Vice President - Clinical, Regulatory and Quality
• Juliet Cunningham,
  Vice President - Investor Relations
• Lori Ciano,
  Chief Human Resource Officer
• Roderick MacLeod,
  Chief Financial Officer
• Dr. David Caraway,
  Chief Medical Officer
• Lori M. Ciano,
  Chief HR Officer
• Patrick Schmitz,
  VP of Operations
• Jon R. Shear,
  VP of Corp. Devel.
• Michael Collier Carter,
  VP of Global Sales
• Julie D. Dewey,
  Chief Corp. Communications & Investor Relations Officer
• Sridhar Kosaraju,
  
• James Alecxih,
  Vice President, Sales
• Lisa D Earnhardt,
  Director
• Andre Walker,
  Senior VP,Research&Development
• Ali Behbahani,
  Director
• Kevin R Thornal,
  President & CEO
• Rami Elghandour,
  President
• Michael Enxing,
  VP of Sales & Marketing
• Arch Management Iv, L.L.C.T...,
  
• City Capital Llc Bay City C...,
  
• Holdings A/S Novo,
  10% owner
• Partners Ii Lp Amv,
  
• City Capital Llc Bay City C...,
  
• Nathan B Pliam,
  Director
• & Johnson Johnson & Johnson...,
  
• Balakrishnan Shankar,
  VP, Operations
• Andrew H Galligan,
  Chief Financial Officer
• Doug Alleavitch,
  VP, Quality
• Kirt P Karros,
  
• Christofer Christoforou,
  SVP, Chief Operating Officer
• Greg Siller,
  SVP & Chief Commercial Officer
• Richard B. Carter,
  Chief Accounting Officer
• Susan E Siegel,